4//SEC Filing
Rosen Steven H 4
Accession 0000899243-22-036080
CIK 0000742112other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 9:53 PM ET
Size
13.1 KB
Accession
0000899243-22-036080
Insider Transaction Report
Form 4
Rosen Steven H
10% OwnerOther
Transactions
- Sale
Common Shares, no par value
2022-11-16$0.49/sh−20,000$9,720→ 3,788,053 total(indirect: By LLC) - Sale
Common Shares, no par value
2022-11-15$0.50/sh−78,025$38,700→ 3,808,053 total(indirect: By LLC) - Sale
Common Shares, no par value
2022-11-14$0.50/sh−60,480$30,361→ 3,886,078 total(indirect: By LLC)
Transactions
- Sale
Common Shares, no par value
2022-11-14$0.50/sh−60,480$30,361→ 3,886,078 total(indirect: By LLC) - Sale
Common Shares, no par value
2022-11-15$0.50/sh−78,025$38,700→ 3,808,053 total(indirect: By LLC) - Sale
Common Shares, no par value
2022-11-16$0.49/sh−20,000$9,720→ 3,788,053 total(indirect: By LLC)
Footnotes (5)
- [F1]The price reported in column 4 is a weighted average price. These common shares, no par value (the "Common Shares"), were sold in multiple transactions at prices ranging from $0.510 to $0.517, inclusive. The Reporting Persons undertake to provide to Invacare Corporation (the "Issuer"), any securityholder of the Issuer or the staff of the Securities and Exchange Commission ("SEC Staff"), upon request, full information regarding the number of shares sold at each price within the range specified herein.
- [F2]The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $0.500 to $0.505, inclusive. The Reporting Persons undertake to provide to the Issuer, any securityholder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
- [F3]The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $0.490 to $0.493, inclusive. The Reporting Persons undertake to provide to the Issuer, any securityholder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
- [F4]Azurite Management LLC ("Azurite") is the owner of record of all such Common Shares. Mr. Rosen, in his capacity as the sole manager of Azurite, has the ability to indirectly control the decisions of Azurite regarding the vote and disposition of securities held by Azurite, and as such may be deemed to have indirect beneficial ownership of the Common Shares held by Azurite. The Reporting Persons disclaim beneficial ownership of the Common Shares owned by Azurite, except to the extent of his pecuniary interest therein.
- [F5]This Form 4 is being filed as a result of sales of Common Shares by Azurite. The sales were effected at prices below the prices of the purchases reported in the Form 4s filed by the Reporting Persons on June 7, 2022 (as amended on June 8, 2022) and June 27, 2022, such that there is no profit for purposes of Section 16(b) and the rules promulgated thereunder.
Documents
Issuer
INVACARE CORP
CIK 0000742112
Entity typeother
Related Parties
1- filerCIK 0001535144
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 9:53 PM ET
- Size
- 13.1 KB